Literature DB >> 21350702

What's hot in inflammatory bowel disease in 2011?

Silvio Danese.   

Abstract

Ulcerative colitis and Crohn's disease (CD) are the two major forms of inflammatory bowel disease (IBD). In this highlight topic series of articles, the most recent advances in the IBD field are reviewed, especially the newly described cytokines, including the therapeutic implications for their manipulation. In addition, the interplay between the intestinal microbiota and the host is reviewed, including the role of defensins and dysbiosis in CD pathogenesis. Finally, the importance of the non immune systems such as endothelial cells and the hemostatic system are highlighted as new players in IBD pathogenesis.

Entities:  

Keywords:  Crohn’s disease; Immunology; Inflammatory bowel disease; Pathogenesis; Ulcerative colitis

Mesh:

Substances:

Year:  2011        PMID: 21350702      PMCID: PMC3040325          DOI: 10.3748/wjg.v17.i5.545

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  6 in total

Review 1.  Extraluminal factors contributing to inflammatory bowel disease.

Authors:  Arvind Batra; Thorsten Stroh; Britta Siegmund
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

Review 2.  Defensins couple dysbiosis to primary immunodeficiency in Crohn's disease.

Authors:  Mathias Chamaillard; Rodrigue Dessein
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

Review 3.  Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.

Authors:  Franco Scaldaferri; Stefano Lancellotti; Marco Pizzoferrato; Raimondo De Cristofaro
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

Review 4.  Role of the endothelium in inflammatory bowel diseases.

Authors:  Walter E Cromer; J Michael Mathis; Daniel N Granger; Ganta V Chaitanya; J Steven Alexander
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

5.  Intestinal microbiota in inflammatory bowel disease: friend of foe?

Authors:  Francesca Fava; Silvio Danese
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

Review 6.  Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases.

Authors:  Guillaume Bouguen; Jean-Baptiste Chevaux; Laurent Peyrin-Biroulet
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

  6 in total
  2 in total

1.  [Stress-related alteration of urine compositions: idiopathic CaOx stone formers, patients with chronic inflammatory bowel disease (CIBD) and healthy controls].

Authors:  W Berg; C Uhlemann; A Meissner; N Laube
Journal:  Urologe A       Date:  2011-12       Impact factor: 0.639

Review 2.  Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.

Authors:  Cristina-Sorina Cătană; Ioana Berindan Neagoe; Vasile Cozma; Cristian Magdaş; Flaviu Tăbăran; Dan Lucian Dumitraşcu
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.